The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Autoimmune Lymphoproliferative Syndrome with Somatic Fas Mutations
Open accessAbstract
BACKGROUND: Impaired Fas-induced apoptosis of lymphocytes in vitro is a principal feature of the autoimmune lymphoproliferative syndrome (ALPS). We studied six children with ALPS whose lymphocytes had normal sensitivity to Fas-induced apoptosis in vitro. METHODS: Susceptibility to Fas-mediated apoptosis and the Fas gene were analyzed in purified subgroups of T cells and other mononuclear cells from six patients with ALPS type III. RESULTS: Heterozygous dominant Fas mutations were detected in the polyclonal double-negative T cells from all six patients. In two patients, these mutations were found in a fraction of CD4+ and CD8+ T cells, monocytes, and CD34+ hematopoietic precursors, but not in hair or mucosal epithelial cells. CONCLUSIONS: Somatic heterozygous mutations of Fas can cause a sporadic form of ALPS by allowing lymphoid precursors to resist the normal process of cell death.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The TNF and TNF Receptor Superfamilies
Locksley, R. M., Killeen, N., & Lenardo, M. J. (2001) · Cell · doi:10.1016/s0092-8674(01)00237-9 · Cited by 3,650
Fisher, G. H., Rosenberg, F. J., Straus, S. E., Dale, J. K., Middelton, L. A., Lin, A. Y., Strober, W., Lenardo, M. J., & Puck, J. M. (1995) · Cell · doi:10.1016/0092-8674(95)90013-6 · Cited by 1,465
Mutations in Fas Associated with Human Lymphoproliferative Syndrome and Autoimmunity
Rieux-Laucat, F., Le Deist, F., Hivroz, C., Roberts, I. A. G., Debatin, K. M., Fischer, A., & de Villartay, J. P. (1995) · Science · doi:10.1126/science.7539157 · Cited by 1,297
Self-citationSustained Correction of X-Linked Severe Combined Immunodeficiency by ex Vivo Gene Therapy
Hacein-Bey-Abina, S., Le Deist, F., Carlier, F., Bouneaud, C., Hue, C., De Villartay, J.-P., Thrasher, A. J., Wulffraat, N., Sorensen, R., Dupuis-Girod, S., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012616 · Cited by 1,058
Self-citationFas and Fas ligand: lpr and gld mutations
Nagata, S., & Suda, T. (1995) · Immunology Today · doi:10.1016/0167-5699(95)80069-7 · Cited by 892
Wang, J., Zheng, L., Lobito, A., Chan, F. K.-M., Dale, J., Sneller, M., Yao, X., Puck, J. M., Straus, S. E., & Lenardo, M. J. (1999) · Cell · doi:10.1016/s0092-8674(00)80605-4 · Cited by 640
Drappa, J., Vaishnaw, A. K., Sullivan, K. E., Chu, J.-L., & Elkon, K. B. (1996) · New England Journal of Medicine · doi:10.1056/nejm199611283352204 · Cited by 480
Fas ligand mutation in a patient with systemic lupus erythematosus and lymphoproliferative disease.
Wu, J., Wilson, J., He, J., Xiang, L., Schur, P. H., & Mountz, J. D. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118892 · Cited by 472
Sneller, M. C., Wang, J., Dale, J. K., Strober, W., Middelton, L. A., Choi, Y., Fleisher, T. A., Lim, M. S., Jaffe, E. S., Puck, J. M., et al. (1997) · Blood · doi:10.1182/blood.v89.4.1341 · Cited by 371
Stephan, V., Wahn, V., Le Deist, F., Dirksen, U., Bröker, B., Müller-Fleckenstein, I., Horneff, G., Schroten, H., Fischer, A., & de Saint Basile, G. (1996) · New England Journal of Medicine · doi:10.1056/nejm199611213352104 · Cited by 267
Self-citationHirschhorn, R., Yang, D. R., Puck, J. M., Huie, M. L., Jiang, C.-K., & Kurlandsky, L. E. (1996) · Nature Genetics · doi:10.1038/ng0796-290 · Cited by 227
Autoimmune Lymphoproliferative Syndrome with Defective Fas: Genotype Influences Penetrance
Jackson, C. E., Fischer, R. E., Hsu, A. P., Anderson, S. M., Choi, Y., Wang, J., Dale, J. K., Fleisher, T. A., Middelton, L. A., Sneller, M. C., et al. (1999) · The American Journal of Human Genetics · doi:10.1086/302333 · Cited by 210
The role of CD95 in the regulation of peripheral T‐cell apoptosis
Krueger, A., Fas, S. C., Baumann, S., & Krammer, P. H. (2003) · Immunological Reviews · doi:10.1034/j.1600-065x.2003.00047.x · Cited by 204
Bettinardi, A., Brugnoni, D., Quiròs-Roldan, E., Malagoli, A., La Grutta, S., Correra, A., & Notarangelo, L. D. (1997) · Blood · doi:10.1182/blood.v89.3.902 · Cited by 190
Chronic lymphadenopathy simulating malignant lymphoma
Canale, V. C., & Smith, C. H. (1967) · The Journal of Pediatrics · doi:10.1016/s0022-3476(67)80262-2 · Cited by 185
Clinical, immunological, and pathological consequences of Fas-deficient conditions
Le Deist, F., Emile, J.-F., Rieux-Laucat, F., Benkerrou, M., Roberts, I., Brousse, N., & Fischer, A. (1996) · The Lancet · doi:10.1016/s0140-6736(96)02293-3 · Cited by 183
Self-citationChronic lymphadenopathy simulating malignant lymphoma
Canale, V., & Smith, C. H. (1966) · The Journal of Pediatrics · doi:10.1016/s0022-3476(66)80576-0 · Cited by 162
The molecular basis for apoptotic defects in patients with CD95 (Fas/Apo-1) mutations
Vaishnaw, A. K., Orlinick, J. R., Chu, J., Krammer, P. H., Chao, M. V., & Elkon, K. B. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5121 · Cited by 154
Somatic Mosaicism in Hemophilia A: A Fairly Common Event
Leuer, M., Oldenburg, J., Lavergne, J. M., Ludwig, M. Z., Fregin, A., Eigel, A., Ljung, R. C. R., Goodeve, A. C., Peake, I. R., & Olek, K. (2001) · The American Journal of Human Genetics · doi:10.1086/321285 · Cited by 151
Somatic mosaicism in Wiskott–Aldrich syndrome suggests in vivo reversion by a DNA slippage mechanism
Wada, T., Schurman, S. H., Otsu, M., Garabedian, E., Ochs, H. D., Nelson, D. L., & Candotti, F. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.151260498 · Cited by 147
Rieux‐Laucat, F., Blachère, S., Danielan, S., de Villartay, J., Oleastro, M., Solary, É., Bader‐Meunier, B., Arkwright, P. D., Pondaré, C., Bernaudin, F., et al. (1999) · Blood · doi:10.1182/blood.v94.8.2575.420k17_2575_2582 · Cited by 145
Self-citationSimon, H., Yousefi, S., Dommann-Scherrer, C. C., Zimmermann, D., Bauer, S., Barandun, J., & Blaser, K. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.183.3.1071 · Cited by 145
Cell-death signaling and human disease
Rieux‐Laucat, F., Fischer, A., & Deist, F. L. (2003) · Current Opinion in Immunology · doi:10.1016/s0952-7915(03)00042-6 · Cited by 129
Self-citationSomatic gene mutation and human disease other than cancer
Erickson, R. P. (2003) · Mutation Research/Reviews in Mutation Research · doi:10.1016/s1383-5742(03)00010-3 · Cited by 115
Ramenghi, U., Bonissoni, S., Migliaretti, G., et al. (2000) · PubMed · Cited by 101
Novel Fas (CD95/APO-1) mutations in infants with a lymphoproliferative disorder.
Kasahara, Y., Wada, T., Niida, Y., Yachie, A., Seki, H., Ishida, Y., Sakai, T., Koizumi, F., Koizumi, S., Miyawaki, T., et al. (1998) · International Immunology · doi:10.1093/intimm/10.2.195 · Cited by 94
Bleesing, J., Brown, M. R., Dale, J. K., Straus, S. E., Lenardo, M. J., Puck, J. M., Atkinson, T. P., & Fleisher, T. A. (2001) · Clinical Immunology · doi:10.1006/clim.2001.5069 · Cited by 92
Ramenghi, U., Bonissoni, S., Migliaretti, G., DeFranco, S., Bottarel, F., Gambaruto, C., DiFranco, D., Priori, R., Conti, F., Dianzani, I., et al. (2000) · Blood · doi:10.1182/blood.v95.10.3176 · Cited by 82
van der Burg, M., de Groot, R., Comans-Bitter, W. M., den Hollander, J. C., Hooijkaas, H., Neijens, H. J., Berger, R. M. F., Oranje, A. P., Langerak, A. W., & van Dongen, J. J. M. (2000) · Pediatric Research · doi:10.1203/00006450-200003000-00009 · Cited by 64
Increased Fetal and Extramedullary Hematopoiesis in Fas-Deficient C57BL/6-lpr/lpr Mice
Schneider, E., Moreau, G., Arnould, A., Vasseur, F., Khodabaccus, N., Dy, M., & Ezine, S. (1999) · Blood · doi:10.1182/blood.v94.8.2613.420k33_2613_2621 · Cited by 59
Bensoussan, D., Deist, F. L., Latger‐Cannard, V., Gregoire, M., Avinens, O., Feugier, P., Bourdon, V., André-Botté, C., Schmitt, C., Jonveaux, P., et al. (2002) · British Journal of Haematology · doi:10.1046/j.1365-2141.2002.03496.x · Cited by 23
Cited by
Genetics of Follicular Lymphoma Transformation
Pasqualucci, L., Khiabanian, H., Fangazio, M., Vasishtha, M., Messina, M., Holmes, A. B., Ouillette, P., Trifonov, V., Rossi, D., Tabbò, F., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2013.12.027 · Cited by 573
Oliveira, J. B., Bleesing, J. J., Dianzani, U., Fleisher, T. A., Jaffe, E. S., Lenardo, M. J., Rieux-Laucat, F., Siegel, R. M., Su, H. C., Teachey, D. T., et al. (2010) · Blood · doi:10.1182/blood-2010-04-280347 · Cited by 495
Self-citationMultistep Pathogenesis of Autoimmune Disease
Goodnow, C. C. (2007) · Cell · doi:10.1016/j.cell.2007.06.033 · Cited by 427
Biomarkers and Algorithms for the Diagnosis of Vitamin B12 Deficiency
Hannibal, L., Lysne, V., Bjørke-Monsen, A.-L., Behringer, S., Grünert, S. C., Spiekerkoetter, U., Jacobsen, D. W., & Blom, H. J. (2016) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2016.00027 · Cited by 355
Systematic Immunotherapy Target Discovery Using Genome-Scale In Vivo CRISPR Screens in CD8 T Cells
Dong, M. B., Wang, G., Chow, R. D., Ye, L., Zhu, L., Dai, X., Park, J. J., Kim, H. R., Errami, Y., Guzman, C. D., et al. (2019) · Cell · doi:10.1016/j.cell.2019.07.044 · Cited by 330
“, 2016), while dysregulated activation of CD8+ T cells can result in immunopathology and autoimmunity (Gravano and Hoyer, 2013; Holzelova et al., 2004; Valori et al., 2016; Walter and Santamaria, 2005).”
Metadata
- Authors
- Holzelova, E., Vonarbourg, C., Stolzenberg, M.-C., Arkwright, P. D., Selz, F., Prieur, A.-M., Blanche, S., Bartunkova, J., Vilmer, E., Fischer, A., Le Deist, F., & Rieux-Laucat, F.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2004-09-30
- Volume
- 351
- Issue
- 14
- Pages
- 1409-1418
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2079657717
- Cited by
- 336
- References
- 31
- FWCI
- 6.67
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.